Investor Guides
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Neurizon Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
News
ASX Small Caps Lunch Wrap: The ASX is all red after a night to forget for US tech
Health & Biotech
PharmAust raises $7.8 million in hot SPP
Health & Biotech
PharmAust’s monepantel drug hits strategic milestone with selection for prestigious ALS treatment trial
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Stockhead TV
Break it Down: PharmAust cashes up for the fight against MND
Health & Biotech
PharmAust raises $10m as share price soars 100pc year to date
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Tech, Energy weigh down ASX; Schrole up almost 200pc on acquisition deal
News
ASX Small Caps Lunch Wrap: Which European food-babies just can’t handle the heat this week?
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Health stocks flat as ACCC scrutinises Sigma and Chemist Warehouse merger
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
PharmAust’s monepantel drug could be a game-changer for MND/ALS patients, new data shows
News
ASX Small Caps Lunch Wrap: Who somehow managed to be shocked by a Madonna concert this week?
News
Top 10 at 10: Kava stock bags on sales blitz, Treasury Wines pops corks on guidance update
News
Rise and Shine: Everything you need to know before the ASX opens
News
